RAD51C and breast cancer: In a smaller study that included 130 women with triple‐negative breast cancer over the age of 60 years, 12.3% of the women were found to have a pathogenic variant in a breast cancer predisposition gene (BRCA1, BRCA2, PALB2, ATM, and RAD51C).13